BMY
Sign in

Bristol-Myers Squibb Company

BMY · NYQ
Watching
—
Loading prices…
Daily prices

Rank vs the other stocks

Trading model
Hold
35thpercentile
Last 7 sessions
WeakestStrongest

BMY placed in the 35th percentile of the stocks being followed just after the open on . The trading model buys from the top of this list.

Model score
−0.27
Ranked

Old model

Guesses whether the price goes up or down. Latest call: Buy
Not trading
Next day
↑ Up
9% confidence
Next 2 days
↑ Up
27% confidence

Made

Technical signals

Momentum, trend, volatility and volume from recent trading, as of
Momentum
RSI (14)
0.517
Stochastic %K (14)
0.716
Stochastic %D (14)
0.817
Trend
Price vs SMA (20)
0.020
Price vs EMA (26)
0.009
Price vs WMA (20)
0.021
Volatility
Bollinger %B (20/2)
0.677
Bollinger Bandwidth (20/2)
0.111
ATR % (14)
0.030
Volume
OBV change (20)
−0.254
Money Flow Index (14)
0.473
Chaikin Money Flow (20)
−0.084
Returns & Statistics
Return (1)
−0.024
Return (2)
0.006
Overnight gap
−0.005

Technical signals for BMY

Computed from recent prices and volume, as of . The models read these alongside the other signals. 100% of them have enough price history to compute; a 0 with low coverage usually means "not enough history yet", not a real reading.

Momentum

Oscillators that gauge how strongly and how fast the price has been moving — used to spot overbought/oversold conditions and shifts in drive.

RSI (7)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.5527
RSI (14)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.5174
RSI (21)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.5044
Stochastic %K (14)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.7164
Stochastic %D (14)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.8173
Stochastic %K (9)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.7164
Stochastic %D (9)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.8173
Stochastic RSI (14)
RSI rescaled to where it sits in its own recent range (0–1) — a more sensitive overbought/oversold reading.
0.8099
Williams %R (14)
Like the Stochastic, the close's position in the recent range (0 = low, 1 = high).
0.7164
CCI (20)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
0.6327
CCI (40)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
−0.0576
Rate of Change (5)
Log return over the lookback — simple momentum (positive = up).
0.0285
Rate of Change (10)
Log return over the lookback — simple momentum (positive = up).
0.0391
Rate of Change (20)
Log return over the lookback — simple momentum (positive = up).
−0.0119
KDJ %K (9)
Smoothed position of the close in its recent range (0–1).
0.7479
KDJ %D (9)
A further smoothing of KDJ %K.
0.6626
KDJ %J (9)
The fast, sensitive leg of KDJ — exaggerates turns.
0.7251
Ultimate Oscillator (7/14/28)
Buying pressure blended across short, medium and long windows (0–1).
0.4999
True Strength Index (25/13)
Double-smoothed momentum, about −1…+1 (positive = upward drive).
−0.0466

Trend

Moving-average and directional measures of which way the price is trending and how strong that trend is.

Price vs SMA (10)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0247
Price vs SMA (20)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0196
Price vs SMA (50)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
−0.0202
Price vs SMA (100)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0137
Price vs SMA (200)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0475
Price vs EMA (12)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0134
Price vs EMA (26)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0088
Price vs EMA (50)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0021
Price vs EMA (200)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0695
Price vs WMA (20)
How far the close is above/below its weighted moving average.
0.0213
PPO (12/26/9)
Percentage Price Oscillator — MACD expressed as a percent so it compares across stocks. Positive = short-term momentum above long-term.
−0.0046
PPO Signal (12/26/9)
The smoothed signal line of the PPO.
−0.0123
PPO Histogram (12/26/9)
PPO minus its signal line — momentum of the momentum.
0.0077
ADX (14)
Trend strength on a 0–1 scale (direction-agnostic). Higher = a stronger trend.
0.1744
+DI (14)
Strength of upward directional movement (0–1).
0.2864
−DI (14)
Strength of downward directional movement (0–1).
0.2049
Aroon Up (25)
How recently a new high was made (1 = just now).
0.9600
Aroon Down (25)
How recently a new low was made (1 = just now).
0.6800
Aroon Oscillator (25)
Aroon Up minus Down — positive favours an uptrend.
0.2800
Parabolic SAR distance
How far price is from the trailing stop-and-reverse level, as a fraction of price.
0.0727
Parabolic SAR side
+1 when price is above the SAR (uptrend), −1 below.
1.0000
Vortex +VI (14)
Strength of upward trend movement (centred at 0).
0.0257
Vortex −VI (14)
Strength of downward trend movement (centred at 0).
−0.1073
Vortex difference (14)
+VI minus −VI — positive favours an uptrend.
0.1330
MA slope (50/20)
The recent slope of a moving average (positive = rising trend).
−0.0149

Volatility

How much the price is swinging around — wide bands and high readings mean larger, riskier moves.

Bollinger %B (20/2)
Where price sits within its Bollinger Bands (0 = lower band, 1 = upper). Above 1 or below 0 is an extended move.
0.6771
Bollinger Bandwidth (20/2)
How wide the bands are relative to price — bigger means more volatile.
0.1108
ATR % (14)
Average True Range as a percent of price — typical daily swing size.
0.0298
Keltner position (20/10/2)
Where price sits within its Keltner Channel (0–1).
0.5966
Keltner width (20/10/2)
Width of the Keltner Channel relative to price.
0.1260
Donchian position (20)
Where price sits within its recent high–low channel (0–1).
0.7164
Donchian width (20)
Width of the recent high–low channel relative to price.
0.1243
Realized volatility (10)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0290
Realized volatility (20)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0233
Realized volatility (60)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0176
Chaikin Volatility (10/10)
Whether the daily high–low range is expanding (+) or contracting (−).
0.4283
Ulcer Index (14)
A drawdown-based stress measure — higher means deeper/longer dips from recent highs.
5.5958

Volume

Whether trading activity is confirming the price move — money flowing in or out, and unusually heavy or light volume.

OBV change (20)
On-Balance Volume trend — net volume flowing in (+) or out (−).
−0.2537
Money Flow Index (14)
A volume-weighted RSI (0–1). High = strong buying pressure.
0.4730
Chaikin Money Flow (20)
Buying vs selling pressure weighted by volume (−1…+1).
−0.0838
Money Flow Multiplier
Where the close finished in the bar's range, the building block of accumulation/distribution (−1…+1).
−0.7778
Accum/Dist change (20)
Recent change in the Accumulation/Distribution line (buying vs selling pressure).
−0.0838
Price vs VWAP (20)
How far the close is above/below the rolling volume-weighted average price.
0.0206
Force Index (13)
Return times relative volume — the push behind a move.
−0.0178
Ease of Movement (sign) (14)
+1 when price rose easily on light volume, −1 when it fell easily.
−1.0000
Ease of Movement (z) (14)
How unusual today's ease-of-movement is vs recent days.
−0.4319
Volume Rate of Change (14)
Log change in volume vs n days ago — a volume surge/lull.
−0.6783
Volume Rate of Change (25)
Log change in volume vs n days ago — a volume surge/lull.
−1.3282
Relative Volume (z) (20)
How many standard deviations today's volume is above/below its recent average.
−1.0433
Relative Volume (z) (50)
How many standard deviations today's volume is above/below its recent average.
−0.2745
Relative Volume (20)
Today's volume vs its recent average (log scale; >0 = above).
−0.3180
Relative Volume (50)
Today's volume vs its recent average (log scale; >0 = above).
−0.1411

Returns & Statistics

Recent returns over several horizons plus statistical shape (skew, fat tails, drawdown, risk-adjusted return).

Return (1)
Log return over the horizon (positive = up).
−0.0244
Return (2)
Log return over the horizon (positive = up).
0.0059
Return (3)
Log return over the horizon (positive = up).
−0.0032
Return (5)
Log return over the horizon (positive = up).
0.0285
Return (10)
Log return over the horizon (positive = up).
0.0391
Return (20)
Log return over the horizon (positive = up).
−0.0119
Overnight gap
Open vs the prior close — overnight move.
−0.0054
Intraday range
High minus low as a fraction of price — the day's swing.
0.0249
True range
True range (gap-aware swing) as a fraction of price.
0.0275
Return skew (20)
Asymmetry of recent returns — negative means crash-prone tails.
0.6865
Return skew (60)
Asymmetry of recent returns — negative means crash-prone tails.
0.2861
Return kurtosis (20)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
−0.0778
Return kurtosis (60)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
0.5639
Downside deviation (20)
Volatility of only the negative returns — pure downside risk.
0.0145
Downside deviation (60)
Volatility of only the negative returns — pure downside risk.
0.0124
Max drawdown (20)
Largest peak-to-trough drop over the window, as a fraction.
0.1037
Max drawdown (60)
Largest peak-to-trough drop over the window, as a fraction.
0.1591
Return/risk (20)
Average return divided by its volatility — recent risk-adjusted return.
−0.0256
Return/risk (60)
Average return divided by its volatility — recent risk-adjusted return.
−0.0409
Return persistence (20)
Whether up days tend to follow up days (+) or reverse (−).
−0.2119
Return persistence (60)
Whether up days tend to follow up days (+) or reverse (−).
−0.1258
Price z-score (20)
How many standard deviations the price is from its recent average.
0.6905
Price z-score (50)
How many standard deviations the price is from its recent average.
−0.4538
Return z-score (20)
How unusual the latest return is vs recent returns.
−1.0239
Return z-score (50)
How unusual the latest return is vs recent returns.
−1.2956

Latest signals

Loading signals…

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for… Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag to treat unresectable or metastatic melanoma; and Camzyos for the treatment of symptomatic obstructive HCM. The company also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu to treat moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for the reduction of risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug for multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane to treat breast cancer. Further, the company provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC, as well as NSCLC and pancreatic cancer. It sells its products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. The company has a strategic collaboration with Arcus Biosciences, Inc. to develop a treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYQ
Currency
USD

News

No recent news about BMY.

Locations

Bristol-Myers Squibb Company — GLEIF legal address
GLEIF legal, United States
72% match
Bristol-Myers Squibb Company — Wikidata HQ
New York City, United States
78% match

Where the company has offices, plants and other sites. Used to judge supply-chain and regional risk.